Losing: A film that does not recover the investment but loses less than 50% of it Flop: Film that loses 50% or more of its investment * denotes that the film is still running in theatres Explore how ...
Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...
Every time BI publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback